[1]
R. Akter, W. P. Maksymowych, M. L. Martin, and D. B. Hogan, “Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis”, Can Geri J, vol. 23, no. 2, pp. 184-189, Mar. 2020.